Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
13 hedge funds and large institutions have $24M invested in Forward Pharma A/S American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
19% more capital invested
Capital invested by funds: $20.2M → $24M (+$3.75M)
32% less funds holding
Funds holding: 19 → 13 (-6)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$9.24M |
| 2 |
Morgan Stanley
New York
|
+$152K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$45.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.4K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$18.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$6.18M |
| 2 |
AIM
Assured Investment Management
New York
|
-$2.24M |
| 3 |
NM
Newtyn Management
New York
|
-$636K |
| 4 |
Renaissance Technologies
New York
|
-$123K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$111K |
FWP Hedge Fund Activity: Q2 2018 in Review
13 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2018, worth a combined $24M — up 19% from $20.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of FWP and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was BVF Inc, adding an estimated $9.24M. The largest seller was Baupost Group, exiting entirely with an estimated $6.18M sold.
- 13 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2018, down from 19 in Q1 2018.
- Funds reported $24M of Forward Pharma A/S American Depositary Shares stock for Q2 2018, up 19% quarter-over-quarter.
- 3 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2018 and 7 closed out, a net change of -4 holders.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2018 was BVF Inc, an estimated $9.24M added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2018 was Baupost Group, an estimated $6.18M sold.
Based on aggregated 13F filings for Q2 2018.